Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update Life Science Investing
Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer's Disease Conference Life Science Investing
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics Biotech Investing
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs Life Science Investing
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength Life Science Investing
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference Medical Device Investing
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry Biotech Investing
